3001. In older patients with permanent AF and HF, digoxin and bisoprolol did not differ for QoL at 6 mo.
Kotecha D, Bunting KV, Gill SK, et al. Effect of digoxin vs bisoprolol for heart rate control in atrial fibrillation on patient-reported quality of life: the RATE-AF randomized clinical trial. JAMA. 2020;324:2497-508. 33351042.
3002. Putting Medicare Spending for COVID-19 Into Perspective.
Tsai and colleagues used Medicare claims data to examine the characteristics and medical spending of older adults diagnosed with COVID-19 from April through December 2020. The editorialists discuss how the study sheds light on COVID-19's effect on medical care and lays the groundwork for future research.
3003. In obesity with T2DM, biliopancreatic diversion increased T2DM remission vs. medical and lifestyle therapy at 10 y.
Mingrone G, Panunzi S, De Gaetano A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397:293-304. 33485454.
3004. Patient Characteristics and Costs Associated With COVID-19-Related Medical Care Among Medicare Fee-for-Service Beneficiaries.
New cases of COVID-19 continue to occur daily in the United States, and the need for medical treatments continues to grow. Knowledge of the direct medical costs of COVID-19 treatments is limited.
3005. Rapid antigen test had up to 98% sensitivity and 100% specificity for detecting COVID-19 in persons with mild symptoms.
Gremmels H, Winkel BMF, Schuurman R, et al. Real-life validation of the Panbio COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection. EClinicalMedicine. 2021;31:100677. 33521610.
3007. USPSTF recommends against screening adults in the general population for asymptomatic carotid artery stenosis.
U.S. Preventive Services Task Force, Krist AH, Davidson KW, et al. Screening for asymptomatic carotid artery stenosis: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:476-81. 33528542.
3008. Medical Schools as Racialized Organizations: A Primer.
作者: Max Jordan Nguemeni Tiako.;Eugenia C South.;Victor Ray.
来源: Ann Intern Med. 2021年174卷8期1143-1144页
The year 2020 saw the largest social movement in response to the police killings of Black people and anti-Black racism in U.S. history. As a result, medical schools and professional societies such as the American Medical Association and the Association of American Medical Colleges are reckoning with their role in perpetuating racial inequality and the impact of structural racism on medical training. Whether these efforts will translate into meaningful change has yet to be determined. Success depends on a deep understanding of the fundamental role racism plays in how medical schools function and an acknowledgment that current organizational structures and processes often serve to entrench, not dismantle, racial inequities. Drawing on racialized organizations theory from the field of sociology, this article gives an overview of scholarship on race and racism in medical training to demonstrate how seemingly race-neutral processes and structures within medical education, in conjunction with individuals' biases and interpersonal discrimination, serve to reproduce and sustain racial inequality. From entrance into medical school through the residency application process, organizational factors such as reliance on standardized tests to predict future success, a hostile learning climate, and racially biased performance metrics ultimately stunt the careers of trainees of color, particularly those from backgrounds underrepresented in medicine (URM). These compounding disadvantages contribute to URM trainees' lower matching odds, steering into less competitive and lucrative specialties, and burnout and attrition from academic careers. In their commitment against structural racism in medical training and academic medicine, medical schools and larger organizations like the Association of American Medical Colleges should prioritize interventions targeted at these structural barriers to achieve equity.
3009. In COVID-19, tocilizumab reduces all-cause mortality at 28 d.
Ghosn L, Chaimani A, Evrenoglou T, et al. Interleukin-6 blocking agents for treating COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021;3:CD013881. 33734435.
3010. In patients hospitalized with COVID-19, adding azithromycin to usual care did not reduce 28-d mortality.
RECOVERY Collaborative Group. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397:605-12. 33545096.
3011. In recurrent C difficile infection, oral FMT capsules have a pooled cure rate of 82% (low-quality evidence).
Du C, Luo Y, Walsh S, Grinspan A. Oral fecal microbiota transplant capsules are safe and effective for recurrent Clostridioides difficile infection: a systematic review and meta-analysis. J Clin Gastroenterol. 2021;55:300-8. 33471490.
3012. Changes in Dialysis Center Quality Associated With the End-Stage Renal Disease Quality Incentive Program : An Observational Study With a Regression Discontinuity Design.
作者: Kyle H Sheetz.;Laura Gerhardinger.;Andrew M Ryan.;Seth A Waits.
来源: Ann Intern Med. 2021年174卷8期1058-1064页
In 2012, the Centers for Medicare & Medicaid Services started levying performance-based financial penalties against outpatient dialysis centers under the mandatory End-Stage Renal Disease Quality Incentive Program.
3013. Effects of Tai Chi or Conventional Exercise on Central Obesity in Middle-Aged and Older Adults : A Three-Group Randomized Controlled Trial.
作者: Parco M Siu.;Angus P Yu.;Edwin C Chin.;Doris S Yu.;Stanley S Hui.;Jean Woo.;Daniel Y Fong.;Gao X Wei.;Michael R Irwin.
来源: Ann Intern Med. 2021年174卷8期1050-1057页
Central obesity is a major manifestation of metabolic syndrome, which is a common health problem in middle-aged and older adults.
3014. Association Between Mortality and Levels of Autonomous Cortisol Secretion by Adrenal Incidentalomas : A Cohort Study.
作者: Albin Kjellbom.;Ola Lindgren.;Shobitha Puvaneswaralingam.;Magnus Löndahl.;Henrik Olsen.
来源: Ann Intern Med. 2021年174卷8期1041-1049页
Autonomous cortisol secretion in patients with adrenal incidentalomas is associated with increased mortality, but detailed information about the risk associated with specific levels of autonomous cortisol secretion is not available.
3016. Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series.
作者: Caoilfhionn M Connolly.;Brian J Boyarsky.;Jake A Ruddy.;William A Werbel.;Lisa Christopher-Stine.;Jacqueline M Garonzik-Wang.;Dorry L Segev.;Julie J Paik.
来源: Ann Intern Med. 2021年174卷9期1332-1334页 3017. Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.
作者: Olivier Marion.;Arnaud Del Bello.;Florence Abravanel.;Chloé Couat.;Stanislas Faguer.;Laure Esposito.;Anne Laure Hebral.;Jacques Izopet.;Nassim Kamar.
来源: Ann Intern Med. 2021年174卷9期1336-1338页 3018. Rapid and Living Guidance for COVID-19.
In their article, Qaseem and colleagues reported how the American College of Physicians responded to the urgent need for guidance during the COVID-19 pandemic by producing living, rapid practice points. The editorialists discuss the challenges of developing high-quality, up-to-date evidence-based recommendations and how rapid and living reviews and guidelines are important additions to the tools we have available to translate research evidence into improved health outcomes.
|